We do not know the optimal human dosing, long-term safety profile in humans, or whether animal results translate directly to human outcomes
Similarly, ATMs in lean subjects are supported by fatty acid oxidation (FAO), glycolysis and glutaminolysis (anti-inflammatory macrophage), while ATMs in obese subjects depend more on glycolysis (pro-inflammatory macrophage) [9]
Headaches, nausea and digestive problems are possible and blood clots can happen in rare cases, especially in individuals with a history of blood clotting disorders, smoking or certain medical disorders
Regular monitoring and communication with your healthcare team optimize long-term outcomes
Receptor sensitivity in reproductive tissues can change
The LUFA 2.2 test soil originated from Lufa, Speyer, Germany